Peter Hänninen Email

General Counsel . Nanoform

Current Roles

Employees:
196
Revenue:
$39.4M
About
Nanoform Finland Ltd has developed a proprietary technology called Controlled Expansion of Supercritical Solutions (CESS) that allows nanonization of drug particles. Implementing CESS offers new technological and business advantages for the pharmaceutical industry.
Nanoform Address
Viikinkaari 4
Helsinki, null
FIN
Nanoform Email